Pricing
Five things for pharma marketers to know: Wednesday, September 27, 2017
September 27, 2017AbbVie adds context to CEO's comments on drug pricing; Pandora makes a play for pharma ad dollars; shortages expected of drugs manufactured in Puerto Rico
Five things for pharma marketers to know: Tuesday, September 26, 2017
September 26, 2017Patient assistance nonprofit contacted in Aegerion probe; most heavily marketed drugs in Canada offer little therapeutic value; the FDA pans Duchenne drug
Five things for pharma marketers to know: Wednesday, September 13, 2017
September 13, 2017FDA closes pediatric study loophole; little evidence outcomes-based contracts are working; PBMs lobby against transparency efforts
Snubbing Intolerance: Frazier's Path Was Disengagement
September 01, 2017Merck CEO Kenneth Frazier's exit from a presidential manufacturing council may go down as one of the most principled stands by the CEO of a major U.S. company, let alone a drugmaker.
Five things for pharma marketers to know: Thursday, August 31, 2017
August 31, 2017Pfizer develops Minecraft version for kids with hemophilia; Lilly to resubmit baricitinib to the FDA; pricing expert says Novartis CAR-T value contract is 'progress'
Five things for pharma marketers to know: Wednesday, August 30, 2017
August 30, 2017Nonprofits receive FDA approval for Chagas drug; Gilead's buyout of Kite will put it back in pricing fray; most cancer patients don't receive fertility info
Five things for pharma marketers to know: Wednesday, August 23, 2017
August 23, 2017Doctors fret about price of Novartis' experimental CAR-T therapy; study finds digital pillboxes don't improve adherence; India awards Pfizer vaccine patent
Five things for pharma marketers to know: Friday, August 18, 2017
August 18, 2017Lawmakers to investigate pricing of MS drugs; Mylan will pay $465 million to resolve EpiPen allegations; the FDA approves Pfizer's new cancer drug
Study: Hiking the prices of heart drugs led to fewer sales
August 17, 2017Prescription rates dramatically decreased following the price hikes of Valeant's Isuprel and Nitropress in 47 hospitals.
Five things for pharma marketers to know: Wednesday, August 16, 2017
August 16, 2017Gottlieb criticizes drugmakers for 'gaming the system' on generics; investors ignore Trump's pharma criticism; docs are more supportive of single payer
Frazier's call earns him praise, rare for a pharma CEO
August 15, 2017It's not often that pharmaceutical companies are held up as examples of morality or leadership to the general public.
Questions About Promotion Prompt Marketers to Develop Code of Ethics
August 15, 2017That's why the Coalition for Healthcare Communication is focused on creating self-regulatory guidelines.
Biogen, Merck use predictive modeling to better negotiate value-based contracts
August 15, 2017What's holding back value-based pricing deals from moving beyond the pilot phase?
Bill to allow imported drugs from Canada aims to create competition
August 14, 2017The Congressional Budget Office says that Sanders' bill would save the U.S. federal government nearly $7 billion over the next decade.
On Shkreli, Here Are the Lessons for Pharma to Learn and Apply
August 07, 2017Though Shkreli may soon slip from the public eye, separated from his Twitter account and prohibited from trading securities, pharma communicators must learn from these events.
Five things for pharma marketers to know: Monday, July 24, 2017
July 24, 2017Samsung Bioepis launches Remicade biosimilar; WHO encourages uses of generic version of Sovaldi; nearly 20 million people with HIV on treatment
Five things for pharma marketers to know: Tuesday, July 11, 2017
July 11, 2017Trump administration considers outcomes-based approach to lower drug prices; Sanofi to acquire vaccines biotech; Nestle partners with Enterome to develop microbiome-based diagnostics
Five things for pharma marketers to know: Monday, June 26, 2017
June 26, 2017The performance of generic drugs is not always guaranteed; the FDA approves a new blood thinner; Gottlieb wants rejection letters public
Five things for pharma marketers to know: Wednesday, June 21, 2017
June 21, 2017Insurance companies balk at expensive PCSK9 inhibitors; Publicis to focus investments on AI platform; clinical trial reveals Novartis' eye drug requires less frequent injections
Five things for pharma marketers to know: Friday, June 16, 2017
June 16, 2017Apple reportedly working to bring EMRs to iPhone; FDA to study disclosures in ads; Trump admin discussing drug price EO
Five things for pharma marketers to know: Friday, June 9, 2017
June 09, 2017The FDA asks Endo to take opioid off the market; Lilly partners with Swiss biotech; House committee advances PDUFA bill — without off-label provision
Physicians call for DTC ads to include retail prices
June 05, 2017They are asking the American Medical Association to support the policy proposal.
Five things for pharma marketers to know: Monday, June 5, 2017
June 05, 2017Medicare beneficiaries struggle to pay for COPD inhalers; Novartis partners with IBM Watson Health; Mylan hasn't lowered EpiPen prices
Five things for pharma marketers to know: Thursday, June 1, 2017
June 01, 201750% of consumers say they will share their health data with tech giants; pharma CEOs expect pricing proposal from Trump administration; FDA approves generic versions of Strattera
Keep Calm and Sell Drugs: Your New Daily Affirmation?
June 01, 2017To be sure, anything borrowing from the well-known "Keep Calm" genre should not be construed as advice. The doctor is definitely not in.
In Surprising Twist, Trust Rises for Healthcare Companies
May 23, 2017But will pharma and biotechnology firms be able to advance this year's positive momentum?
Five things for pharma marketers to know: Tuesday, May 9, 2017
May 09, 2017Sanofi ties price increases to growth rate; Regeneron to target 7,000 docs on new eczema drug Dupixent; NIH and biotech execs meet White House officials
Five things for pharma marketers to know: Monday, May 8, 2017
May 08, 2017Pfizer to provide Ibrance for free during NICE analysis; the FDA approves new ALS drug; people turn to Twitter to tell stories about pre-existing conditions
Five things for pharma marketers to know: Thursday, May 4, 2017
May 04, 2017Louisiana may use 1910 law to discount hep-C drugs; House bill would reduce coverage for 24 million people; drugmakers pursue pay-for-performance deals
U.S. drug spend grew by 6% in 2016, the lowest rate in two years
May 04, 2017This is likely due to fewer product launches and lower price increases.
